DNA topoisomerase II as a target for cancer chemotherapy.
Walker
Jerrylaine V
JV
Department of Molecular Pharmacology, St. Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, USA.
Nitiss
John L
JL
D004250:DNA Topoisomerases, Type II / Q000235:genetics; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005544:Forecasting; D015870:Gene Expression; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology*; D059005:Topoisomerase II Inhibitors
D004791:Enzyme Inhibitors; D059005:Topoisomerase II Inhibitors; D004250:DNA Topoisomerases, Type II